Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence

Published:2024-03-05 Issue:18 Volume:45 Page:1684-1684
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Urso Stefano¹^ORCID,Sadaba Rafael²^ORCID,Dayan Victor³

Affiliation:

1. Cardiac Surgery Department, Hospital Universitario Dr. Negrín , Barranco de la Ballena, s/n 35010, Las Palmas de Gran Canaria , Spain

2. Cardiac Surgery Department, Hospital Universitario de Navarra , Pamplona , Spain

3. Cardiac Surgery Department, Centro Cardiovascular Universitario, Hospital de Clinicas , Montevideo , Uruguay

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/eurheartj/article-pdf/45/18/1684/57567971/ehae135.pdf

Reference5 articles.

1. PCI or CABG for left main coronary artery disease: the SWEDEHEART registry;Persson;Eur Heart J,2023

2. On the pooling and subgrouping of data from percutaneous coronary intervention versus coronary artery bypass grafting trials: a 411 call to circumspection;Freemantle;Eur J Cardiothorac Surg,2018

3. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis;Sabatine;Lancet,2021

4. Revascularization for left main coronary artery disease;Alfonso;Eur Heart J,2023

5. 2022 joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG;Byrne;Eur J Cardiothorac Surg,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on ischaemic heart disease: prevention with colchicine, role of the brain–heart axis, new therapeutic targets for ischaemia–reperfusion injury;European Heart Journal;2024-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3